Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.

Ishikawa SE.

J Clin Med. 2017 Oct 31;6(11). pii: E102. doi: 10.3390/jcm6110102. Review.

2.

Comparison of the Effects of Carperitide and Tolvaptan on Patients with Left Ventricular Dysfunction: A Two-Center Retrospective Study.

Koeda C, Yamaya S, Hozawa M, Sato M, Nasu K, Takahashi T, Terui K.

Cardiol Res Pract. 2017;2017:6935342. doi: 10.1155/2017/6935342. Epub 2017 Jul 12.

3.

Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure.

Vinod P, Krishnappa V, Chauvin AM, Khare A, Raina R.

Cardiol Res. 2017 Jun;8(3):87-95. doi: 10.14740/cr553w. Epub 2017 Jun 30. Review.

4.

A reduction in SK channels contributes to increased activity of hypothalamic magnocellular neurons during heart failure.

Ferreira-Neto HC, Biancardi VC, Stern JE.

J Physiol. 2017 Oct 15;595(20):6429-6442. doi: 10.1113/JP274730. Epub 2017 Aug 2.

PMID:
28714070
5.

Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF).

Grodin JL, Sun JL, Anstrom KJ, Chen HH, Starling RC, Testani JM, Tang WH.

Am J Cardiol. 2017 Jan 1;119(1):78-83. doi: 10.1016/j.amjcard.2016.09.014. Epub 2016 Sep 30.

6.

Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure.

Kitada S, Kikuchi S, Sonoda H, Yoshida A, Ohte N.

J Int Med Res. 2016 Dec;44(6):1430-1442. doi: 10.1177/0300060516663779. Epub 2016 Oct 27.

7.

Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow.

Zheng H, Patel KP.

Auton Neurosci. 2017 May;204:57-64. doi: 10.1016/j.autneu.2016.08.008. Epub 2016 Aug 6. Review.

PMID:
27527558
8.

A Functional Coupling Between Carbon Monoxide and Nitric Oxide Contributes to Increased Vasopressin Neuronal Activity in Heart Failure rats.

Reis WL, Biancardi VC, Zhou Y, Stern JE.

Endocrinology. 2016 May;157(5):2052-66. doi: 10.1210/en.2015-1958. Epub 2016 Mar 16.

9.

Neurohypophyseal Hormones: Novel Actors of Striated Muscle Development and Homeostasis.

Costa A, Rossi E, Scicchitano BM, Coletti D, Moresi V, Adamo S.

Eur J Transl Myol. 2014 Sep 22;24(3):3790. doi: 10.4081/ejtm.2014.3790. eCollection 2014 Sep 23. Review.

10.
11.

Importance of Abnormal Chloride Homeostasis in Stable Chronic Heart Failure.

Grodin JL, Verbrugge FH, Ellis SG, Mullens W, Testani JM, Tang WH.

Circ Heart Fail. 2016 Jan;9(1):e002453. doi: 10.1161/CIRCHEARTFAILURE.115.002453.

12.

Hyponatremia Associated with Heart Failure: Pathological Role of Vasopressin-Dependent Impaired Water Excretion.

Ishikawa SE.

J Clin Med. 2015 May 8;4(5):933-47. doi: 10.3390/jcm4050933. Review.

13.

Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Wasilewski MA, Myers VD, Recchia FA, Feldman AM, Tilley DG.

Cell Signal. 2016 Mar;28(3):224-233. doi: 10.1016/j.cellsig.2015.07.021. Epub 2015 Jul 30. Review. No abstract available.

14.

Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure.

Cui X, Zhang J, Li Y, Sun Y, Cao J, Zhao M, Zhao Y, Zhao X, He Y, Han A.

Evid Based Complement Alternat Med. 2015;2015:639450. doi: 10.1155/2015/639450. Epub 2015 May 17.

15.

Arginine vasopressin as a target in the treatment of acute heart failure.

Gilotra NA, Russell SD.

World J Cardiol. 2014 Dec 26;6(12):1252-61. doi: 10.4330/wjc.v6.i12.1252. Review.

16.
17.

Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.

Reed BN, Street SE, Jensen BC.

Heart Fail Clin. 2014 Oct;10(4):543-57. doi: 10.1016/j.hfc.2014.07.002. Epub 2014 Aug 14. Review.

18.

Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective.

Song MK, Davies NM, Roufogalis BD, Huang TH.

J Diabetes Res. 2014;2014:313718. doi: 10.1155/2014/313718. Epub 2014 Apr 13. Review.

19.

Increased vasopressin 1A receptor expression in failing human hearts.

Zhu W, Tilley DG, Myers VD, Tsai EJ, Feldman AM.

J Am Coll Cardiol. 2014 Feb 4;63(4):375-6. doi: 10.1016/j.jacc.2013.09.032. Epub 2013 Oct 16. No abstract available.

20.

Hyponatremia in patients with heart failure.

Filippatos TD, Elisaf MS.

World J Cardiol. 2013 Sep 26;5(9):317-28. doi: 10.4330/wjc.v5.i9.317. Review.

Supplemental Content

Support Center